AVXL übertreffen die 24 der letzten 36Schätzungen.
67%
Nächster Bericht
Datum des nächsten Berichts
05. Feb. 2026
Estimate forQ1 26(Revenue/ EPS)
--
/
-$0.11
Implizierte Änderung vonQ4 25(Revenue/ EPS)
--
/
--
Implizierte Änderung vonQ1 25(Revenue/ EPS)
--
/
-21.43%
Anavex Life Sciences earnings per share and revenue
On 25. Nov. 2025, AVXL reported earnings of -0.11 USD per share (EPS) for Q4 25, beating the estimate of -0.15 USD, resulting in a 28.10% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +11.56% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of -0.11 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Anavex Life Sciences's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Anavex Life Sciences reported EPS of -$0.11, beating estimates by 28.1%, and revenue of $0.00, 0% as expectations.
How did the market react to Anavex Life Sciences's Q4 2025 earnings?
The stock price moved up 11.56%, changed from $3.46 before the earnings release to $3.86 the day after.
When is Anavex Life Sciences expected to report next?
The next earning report is scheduled for 05. Feb. 2026.
What are the forecasts for Anavex Life Sciences's next earnings report?
Based on 5
analysts, Anavex Life Sciences is expected to report EPS of -$0.11 and revenue of -- for Q1 2026.